Efficacy and safety of front-line treatment regimens for Waldenstrom macroglobulinaemia: a systematic review and meta-analysis
Blood Cancer Journal, Published online: 07 September 2023; doi:10.1038/s41408-023-00916-5Efficacy and safety of front-line treatment regimens for Waldenstrom macroglobulinaemia: a systematic review and meta-analysis (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 7, 2023 Category: Hematology Authors: Wee-Lee Chan Vanessa Cui Lian Chong Ian Jun Yan Wee Li Mei Poon Esther Hian Lee Chan Joanne Lee Yen-Lin Chee Anand D. Jeyasekharan Wee-Joo Chng Miny Samuel Sanjay de Mel Source Type: research
Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemia
Blood Cancer Journal, Published online: 06 September 2023; doi:10.1038/s41408-023-00908-5Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemia (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 6, 2023 Category: Hematology Authors: Beth A. Pitel Cinthya Zepeda-Mendoza Zohar Sachs Hongwei Tang Suganti Shivaram Neeraj Sharma James B. Smadbeck Stephanie A. Smoley Kathryn E. Pearce Ivy M. Luoma Joselle Cook Mark R. Litzow Nicole L. Hoppman David Viswanatha Xinjie Xu Rhett P. Ketterling Source Type: research
Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database
Blood Cancer Journal, Published online: 05 September 2023; doi:10.1038/s41408-023-00905-8Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 5, 2023 Category: Hematology Authors: Julie C ôté Richard LeBlanc Hira Mian Michael P. Chu Arleigh McCurdy Esther Masih-Khan Jiandong Su Victor H. Jimenez-Zepeda Kevin Song Martha Louzada Darrell White Michael Sebag Anthony Reiman Julie Stakiw Rami Kotb Debra Bergstrom Muhammad Aslam Rayan Source Type: research
Cell-free DNA chromosome copy number variations predict outcomes in plasma cell myeloma
Blood Cancer Journal, Published online: 05 September 2023; doi:10.1038/s41408-023-00904-9Cell-free DNA chromosome copy number variations predict outcomes in plasma cell myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 5, 2023 Category: Hematology Authors: Wanting Qiang Lina Jin Tiancheng Luo Yanchun Jia Jing Lu Jin Liu Haiyan He Ziliang Qian Sridurga Mithraprabhu Yang Liang Robert Peter Gale Xia Tao Depei Wu Juan Du Source Type: research
Identification of NOTCH-driven matrisome-associated genes as prognostic indicators of multiple myeloma patient survival
Blood Cancer Journal, Published online: 05 September 2023; doi:10.1038/s41408-023-00907-6Identification of NOTCH-driven matrisome-associated genes as prognostic indicators of multiple myeloma patient survival (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 5, 2023 Category: Hematology Authors: Daniela Simone Maichl Julius Arthur Kirner Susanne Beck Wen-Hui Cheng Melanie Krug Martin Kuric Carsten Patrick Ade Thorsten Bischler Franz Jakob Dirk Hose Anja Seckinger Regina Ebert Franziska Jundt Source Type: research
Clinical and immunological characteristics of prolonged SARS-CoV-2 Omicron infection in hematologic disease
Blood Cancer Journal, Published online: 05 September 2023; doi:10.1038/s41408-023-00897-5Clinical and immunological characteristics of prolonged SARS-CoV-2 Omicron infection in hematologic disease (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 5, 2023 Category: Hematology Authors: Daisuke Ikeda Ami Fukumoto Yuka Uesugi Rikako Tabata Daisuke Miura Kentaro Narita Masami Takeuchi Tomohisa Watari Yoshihito Otsuka Kosei Matsue Source Type: research
Clinical characteristics, genomic profiling and outcomes of single system multifocal Langerhans cell histiocytosis in adults with bone involvement
Blood Cancer Journal, Published online: 05 September 2023; doi:10.1038/s41408-023-00913-8Clinical characteristics, genomic profiling and outcomes of single system multifocal Langerhans cell histiocytosis in adults with bone involvement (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 5, 2023 Category: Hematology Authors: Hong-xiao Han Long Chang Min Lang He Lin Jian Li Ming-hui Duan Dao-bin Zhou Xin-xin Cao Source Type: research
Gemtuzumab ozogamicin plus standard induction chemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia
Blood Cancer Journal, Published online: 04 September 2023; doi:10.1038/s41408-023-00910-xGemtuzumab ozogamicin plus standard induction chemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 4, 2023 Category: Hematology Authors: Hassan Awada Mina Abdelmalek Tara Cronin Jeffrey Baron Zakariya Kashour Farhan Azad Muhammad Salman Faisal Mark Faber Matthew Gravina Pamela J. Sung Steven D. Green Amanda Przespolewski James E. Thompson Elizabeth A. Griffiths Eunice S. Wang Source Type: research
Gemtuzumab ozogamicin plus standard induction hemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia
Blood Cancer Journal, Published online: 04 September 2023; doi:10.1038/s41408-023-00910-xGemtuzumab ozogamicin plus standard induction hemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 4, 2023 Category: Hematology Authors: Hassan Awada Mina Abdelmalek Tara Cronin Jeffrey Baron Zakariya Kashour Farhan Azad Muhammad Salman Faisal Mark Faber Matthew Gravina Pamela J. Sung Steven D. Green Amanda Przespolewski James E. Thompson Elizabeth A. Griffiths Eunice S. Wang Source Type: research
Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study
Blood Cancer Journal, Published online: 04 September 2023; doi:10.1038/s41408-023-00909-4Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 4, 2023 Category: Hematology Authors: Sergio Matarraz Pilar Leoz Ana Yeguas-Bermejo Vincent van der Velden Anne E. Bras Jose I. S ánchez Gallego Quentin Lecrevisse Rosa Ayala-Bueno Cristina Teodosio Ignacio Criado Mar ía González-González Juan Flores-Montero Alejandro Avenda ño Mar ía B Source Type: research
A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics
Blood Cancer Journal, Published online: 01 September 2023; doi:10.1038/s41408-023-00903-wA population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 1, 2023 Category: Hematology Authors: Johanna A. A. Bult Francien Huisman Yujie Zhong Nick Veltmaat Joost Kluiver Sanne H. Tonino Joost S. P. Vermaat Martine E. D. Chamuleau Arjan Diepstra Anke van den Berg Wouter J. Plattel Mirian Brink Marcel Nijland Source Type: research
Correction: Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis
Blood Cancer Journal, Published online: 28 August 2023; doi:10.1038/s41408-023-00888-6Correction: Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 28, 2023 Category: Hematology Authors: Arleigh McCurdy Hira Mian Richard LeBlanc Victor H. Jimenez-Zepeda Jiandong Su Esther Masih-Khan Alissa Visram Martha Louzada Kevin Song Darrell White Michael Sebag Julie Stakiw Anthony Reiman Muhammad Aslam Debra Bergstrom Rami Kotb Rayan Kaedbey Engin G Source Type: research
Favorable outcomes of NPM1mut AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance
Blood Cancer Journal, Published online: 22 August 2023; doi:10.1038/s41408-023-00898-4Favorable outcomes of NPM1mut AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 22, 2023 Category: Hematology Authors: I. Khan A. Kaempf S. Raghuwanshi M. Chesnokov X. Zhang Z. Wang A. Domling J. W. Tyner C. Camacho A. L. Gartel Source Type: research
T-cell phenotype including CD57+ T follicular helper cells in the tumor microenvironment correlate with a poor outcome in follicular lymphoma
Blood Cancer Journal, Published online: 18 August 2023; doi:10.1038/s41408-023-00899-3T-cell phenotype including CD57+ T follicular helper cells in the tumor microenvironment correlate with a poor outcome in follicular lymphoma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 18, 2023 Category: Hematology Authors: Zhi-Zhang Yang Hyo Jin Kim Hongyan Wu Xinyi Tang Yue Yu Jordan Krull Daniel P. Larson Raymond M. Moore Matthew J. Maurer Kevin D. Pavelko Shahrzad Jalali Joshua C. Pritchett Rekha Mudappathi Junwen Wang Jose C. Villasboas Patrizia Mondello Anne J. Novak S Source Type: research
The oncogenic human B-cell lymphoma MYD88 L265P mutation genocopies activation by phosphorylation at the Toll/interleukin-1 receptor (TIR) domain
Blood Cancer Journal, Published online: 18 August 2023; doi:10.1038/s41408-023-00896-6The oncogenic human B-cell lymphoma MYD88 L265P mutation genocopies activation by phosphorylation at the Toll/interleukin-1 receptor (TIR) domain (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 18, 2023 Category: Hematology Authors: Marthe Minderman Hildo Lantermans Carmen van der Zwaan Arie J. Hoogendijk Maartje van den Biggelaar Marie Jos é Kersten Marcel Spaargaren Steven T. Pals Source Type: research
